Search results

In neuroscience, methylene blue can also serve as a non-selective inhibitor of [[NO synthase]]. Methylene blue is a [[monoamine oxidase inhibitor]] (MAOI),<ref>

...mbyax]]''') is an [[antidepressant]] of the [[selective serotonin reuptake inhibitor]] (SSRI) class. It is manufactured and marketed by [[Eli Lilly and Company] ...le=Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication |journ

...1, 2006, in Kyoto, Japan.]</ref> It was named dopamine because it was a [[monoamine]], and its synthetic precursor was 3,4-''d''ihydr''o''xy''p''henyl''a''lani ...e [[dopamine transporter]] (DAT1), then enzymatic breakdown by [[monoamine oxidase]] ([[MAOA]] and [[MAOB]]) into [[3,4-dihydroxyphenylacetic acid]]. In the p

...n with certain antidepressants, namely [[Serotonin-norepinephrine reuptake inhibitor|SNRI]]s (serotonin-norepinephrine re-uptake inhibitors), as this increases ...rine-dopamine reuptake inhibitor|NDRI]] (norepinephrine-dopamine re-uptake inhibitor). It has an action which bears more resemblance to amphetamine than to [[fl

| group4 = [[Serotonin reuptake inhibitor|Reuptake inhibitors]] | group2 = [[Vesicular monoamine transporter|VMAT]]

| group1 = Specific [[reuptake]] [[Reuptake inhibitor|inhibitor]]s (RIs), [[Reuptake enhancer|enhancer]]s (REs), and [[Releasing agent|rele ...mall>[[Selective serotonin reuptake inhibitor|Selective serotonin reuptake inhibitor]]s (SSRIs)</small>

| group1 = [[Monoamine oxidase inhibitor|MAOI]] | group2 = [[Norepinephrine reuptake inhibitor|Adrenergic uptake inhibitor]]

|name = Monoamine oxidase inhibitors |title= [[Monoamine oxidase inhibitor]]s

| group2 = [[Norepinephrine reuptake inhibitor|Reuptake inhibitors]] | group2 = [[Vesicular monoamine transporter|VMAT]]

| group1 = [[Serotonin reuptake inhibitor|Serotonin Reuptake Inhibitor]]s ...euptake inhibitor|SNRI]]s • [[Serotonin-norepinephrine-dopamine reuptake inhibitor|SNDRI]]s • [[Tricyclic antidepressant|TCA]]s • .....

| group3 = [[Monoamine oxidase B|MAO-B]] [[Monoamine oxidase inhibitor|inhibitor]]s | group4 = [[Catechol-O-methyl transferase|COMT]] [[COMT inhibitor|inhibitor]]s

| group2 = [[Dopamine reuptake inhibitor|Reuptake inhibitors]] | group1 = [[Dopamine reuptake inhibitor|DAT inhibitors]]

* Patients taking [[Monoamine oxidase inhibitor|MAO inhibitors]] can experience a severe [[hypertension|hypertensive]] cris

...s system|sympathetic]] [[neuron]]s with chronic use of [[monoamine oxidase inhibitor]]s. It may be responsible for the common [[side effect]] of [[orthostatic h

...and should not be co-administered with any selective [[serotonin reuptake inhibitor]] (SSRI) antidepressant such as [[fluoxetine]]), or any medication which af

...ithin [[Synaptic vesicle|vesicles]]; and [[deprenyl]] inhibits [[monoamine oxidase]] (MAO)-B and thus increases dopamine levels. * [[Prozac]] is a [[serotonin reuptake inhibitor|selective serotonin reuptake inhibitor]] (SSRI), hence potentiating the effect of naturally released serotonin.

...me="pmid16051647">{{cite journal | author = Gillman PK | title = Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity | journal = British Jo ...t of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase | journal=The FASEB Journal | date=20 January 2004| pmid= 14734632 | doi= 1